文献速递前列腺增生与排尿功能障碍

良性前列腺增生的消融性微创手术治疗:Aquablation、Rezum及经会阴激光前列腺消融综述

Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-04-20

本文综述了Aquablation、Rezum和经会阴前列腺激光消融(TPLA)三种消融性微创手术的技术、安全性及围手术期和功能结局,重点讨论性功能保护。Aquablation 5年功能结局持续且对性活动无影响;Rezum显著改善Qmax和IPSS并保留性功能;TPLA改善Qmax、IPSS和QoL并保留射精功能。

要点

  • Aquablation为术者引导、机器人执行的无热消融水刀手术,5年功能结局持续且对性活动无影响。
  • Rezum为诊室基对流蒸汽热消融,显著改善Qmax和IPSS并保留性功能。
  • TPLA为诊室基二极管激光热消融,改善Qmax、IPSS和QoL并保留射精功能。

核心结论

  • 消融性微创手术疗法总体表现出极好的安全性和有效性,同时保留性功能。
  • 应与患者讨论这些方式以确保知情和共享决策。
  • 消融性微创手术疗法可能特别适合重视保留性功能的患者。

研究设计与样本

  • 综述,讨论Aquablation、Rezum和TPLA三种消融性微创手术的技术、安全性及围手术期和功能结局。
  • 进一步详细讨论这些消融性微创手术治疗后的性功能。

主要发现

  • Aquablation为术者引导、机器人执行的无热消融水刀手术,5年功能结局持续且对性活动无影响。
  • Rezum为诊室基微创手术选项,将对流蒸汽能量递送至前列腺腺瘤以消融梗阻组织,显著改善Qmax和IPSS并保留性功能。
  • TPLA为诊室基技术,使用二极管激光源产生热消融,改善Qmax、IPSS和QoL并保留射精功能。

临床怎么用

  • 作者认为消融性微创手术疗法应与患者讨论以确保知情和共享决策。
  • 作者认为消融性微创手术疗法可能特别适合重视保留性功能的患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting men and can present with bothersome lower urinary tract symptoms (LUTS). Historically, transurethral resection of the prostate (TURP) has been considered the gold standard in the treatment of LUTS due to BPH. However, TURP and other traditional options for the surgical management of LUTS secondary to BPH are associated with high rates of sexual dysfunction. In the past decade, several novel technologies, including Aquablation therapy, convective water vapor therapy (Rezum), and transperineal prostate laser ablation (TPLA), have demonstrated promising evidence to be safe and effective while preserving sexual function. METHODS: In this review, we discuss three ablative minimally invasive surgeries: Aquablation, Rezum, and TPLA. We review their techniques, safety, as well as perioperative and functional outcomes. We go into further detail regarding sexual function after these ablative minimally invasive surgical therapies. RESULTS: Aquablation is a surgeon-guided, robot-executed, heat-free ablative waterjet procedure with sustained functional outcomes at 5 years while having no effect on sexual activity. Rezum is an innovative office-based, minimally invasive surgical option for BPH that delivers convective water vapor energy into prostate adenoma to ablate obstructing tissue. Rezum leads to significant improvements in Qmax, IPSS while preserving sexual function. TPLA is another office-based technology which uses a diode laser source to produce thermoablation. It leads to improvement in Qmax, IPSS, and QoL while preserving ejaculatory function. CONCLUSIONS: Overall, ablative minimally invasive surgical therapies have demonstrated excellent safety and efficacy profiles while preserving sexual function. These modalities should be discussed with patients to ensure informed and shared decision-making. Ablative minimally invasive surgical therapies may be particularly interesting to patients who value the preservation of their sexual function.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Nguyen DD, Li T, Ferreira R, et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis. 2023. PMID: 37081044. doi:10.1038/s41391-023-00669-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。